TG Therapeutics | TGTX - SCHULD





SCHULD Veränderung Datum
AbbVie USD 67.5B 67.5B 2025-12
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.6B 17M 2025-12
Ardelyx USD 208.26M 653K 2026-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 6.56B 275.1M 2026-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Curis USD 0 0 2022-06
Gilead Sciences USD 24.94B 5M 2025-12
J&J USD 47.93B 2.14B 2025-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 47B 11.62B 2026-03
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 253.71M 8.37M 2025-12
Verastem USD 66.79M 26.7M 2024-09
Vertex Pharmaceuticals USD 1.99B 44M 2026-03